본문 바로가기
KERD
논문KCI 등재

Fimasartan-Based Blood Pressure Control after Acute Cerebral Ischemia: The Fimasartan-Based Blood Pressure Control after Acute Cerebral Ischemia Study

김범준|이용석|김용재|박종호|권지현|최재철|이경열|하상원|정진만|안성환|남효석|나정호|박만석|구자성|김응규|박종무|오미선|황양하|이경복|방오영|이수주|배희준|권순억|손성일|성상민|차재관|홍근식
대한신경과학회 (Korean Neurological Association)|2021.07|Journal of Clinical Neurology|제17권 제3호|pp. 344-353|DOI 10.3988/jcn.2021.17.3.344

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

blood pressurestrokeprevention and controlfimasartan.

초록

Background and Purpose Blood pressure (BP) control is strongly recommended, but BP control rate has not been well studied in patients with stroke. We evaluated the BP control rate with fimasartan-based antihypertensive therapy initiated in patients with recent cerebral ischemia. Methods This multicenter, prospective, single-arm trial involved 27 centers in South Korea. Key inclusion criteria were recent cerebral ischemia within 90 days and high BP [systolic blood pressure (SBP) >140 mm Hg or diastolic blood pressure (DBP) >90 mm Hg]. BP lowering was initiated with fimasartan. BP management during the follow-up was at the discretion of the responsible investigators. The primary endpoint was the target BP goal achievement rate (<140/90 mm Hg) at 24 weeks. Key secondary endpoints included achieved BP and BP changes at each visit, and clinical events (ClinicalTrials.gov Identifier: NCT03231293). Results Of 1,035 patients enrolled, 1,026 were included in the safety analysis, and 951 in the efficacy analysis. Their mean age was 64.1 years, 33% were female, the median time interval from onset to enrollment was 10 days, and the baseline SBP and DBP were 162.3±16.0 and 92.2±12.4 mm Hg (mean±SD). During the study period, 55.5% of patients were maintained on fimasartan monotherapy, and 44.5% received antihypertensive therapies other than fimasartan monotherapy at at least one visit. The target BP goal achievement rate at 24-week was 67.3% (48.6% at 4-week and 61.4% at 12-week). The mean BP was 139.0/81.8±18.3/11.7, 133.8/79.2±16.4/11.0, and 132.8/78.5±15.6/10.9 mm Hg at 4-, 12-, and 24-week. The treatment- emergent adverse event rate was 5.4%, including one serious adverse event. Conclusions Fimasartan-based BP lowering achieved the target BP in two-thirds of patients at 24 weeks, and was generally well tolerated.

Abstract

Background and Purpose Blood pressure (BP) control is strongly recommended, but BP control rate has not been well studied in patients with stroke. We evaluated the BP control rate with fimasartan-based antihypertensive therapy initiated in patients with recent cerebral ischemia. Methods This multicenter, prospective, single-arm trial involved 27 centers in South Korea. Key inclusion criteria were recent cerebral ischemia within 90 days and high BP [systolic blood pressure (SBP) >140 mm Hg or diastolic blood pressure (DBP) >90 mm Hg]. BP lowering was initiated with fimasartan. BP management during the follow-up was at the discretion of the responsible investigators. The primary endpoint was the target BP goal achievement rate (<140/90 mm Hg) at 24 weeks. Key secondary endpoints included achieved BP and BP changes at each visit, and clinical events (ClinicalTrials.gov Identifier: NCT03231293). Results Of 1,035 patients enrolled, 1,026 were included in the safety analysis, and 951 in the efficacy analysis. Their mean age was 64.1 years, 33% were female, the median time interval from onset to enrollment was 10 days, and the baseline SBP and DBP were 162.3±16.0 and 92.2±12.4 mm Hg (mean±SD). During the study period, 55.5% of patients were maintained on fimasartan monotherapy, and 44.5% received antihypertensive therapies other than fimasartan monotherapy at at least one visit. The target BP goal achievement rate at 24-week was 67.3% (48.6% at 4-week and 61.4% at 12-week). The mean BP was 139.0/81.8±18.3/11.7, 133.8/79.2±16.4/11.0, and 132.8/78.5±15.6/10.9 mm Hg at 4-, 12-, and 24-week. The treatment- emergent adverse event rate was 5.4%, including one serious adverse event. Conclusions Fimasartan-based BP lowering achieved the target BP in two-thirds of patients at 24 weeks, and was generally well tolerated.

참고문헌 (88)

  1. Stahl JS, "Nystagmus", Curr Neurol Neurosci Rep, 1, pp.471~477 (2001)
  2. Straube A, "Nystagmus : an update on treatment in adults", Expert Opin Pharmacother, 6, pp.583~590 (2005)
  3. Rucker JC, "Current treatment of nystagmus", Curr Treat Options Neurol, 7, pp.69~77 (2005)
  4. Rucker JC, "An update on acquired nystagmus", Semin Ophthalmol, 23, pp.91~97 (2008)
  5. Rucker JC, "Pearls : nystagmus", Semin Neurol, 30, pp.51~53 (2010)
  6. Thurtell MJ, "Nystagmus and saccadic intrusions", Handb Clin Neurol, 102, pp.333~378 (2011)
  7. Strupp M, "including gaze palsy and nystagmus", J Neurol, 261(Suppl 2), pp.S542~S558 (2014)
  8. Leigh RJ, "The Neurology of Eye Movements" (2015), Oxford University Press
  9. Choi JY, "Nystagmus and central vestibular disorders", Curr Opin Neurol, 30, pp.98~106 (2017)
  10. Rucker JC, "Nystagmus and saccadic intrusions", Continuum(Minneap Minn), 25, pp.1376~1400 (2019)
  11. Fukushima K, "The neuronal substrate of integration in the oculomotor system", Prog Neurobiol, 39, pp.609~639 (1992)
  12. Sharpe JA, "Saccadic intrusions and oscillations", Can J Neurol Sci, 11, pp.426~433 (1984)
  13. Kim SJ, "Initial degree of spontaneous nystagmus affects the length of hospitalization of patients with vestibular neuritis", Otol Neurotol, 41, pp.836~842 (2020)
  14. Reynard P, "Delayed endolymphatic hydrops. Special emphasis on nystagmus associated with episodes and contribution of chemical labyrinthectomy", Eur Ann Otorhinolaryngol Head Neck Dis, 135, pp.321~326 (2018)
  15. Kattah JC, "Conversion of upbeat to downbeat nystagmus in Wernicke encephalopathy", Neurology, 91, pp.790~796 (2018)
  16. Kattah JC, "Vertical nystagmus in Wernicke’s encephalopathy : pathogenesis and role of central processing of information from the otoliths", J Neurol, 266, pp.139~145 (2019)
  17. Huh SY, "The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders", Mult Scler, 20, pp.695~704 (2014)
  18. Lee SU, "Comparison of ocular motor findings between neuromyelitis optica spectrum disorder and multiple sclerosis involving the brainstem and cerebellum", Cerebellum, 18, pp.511~518 (2019)
  19. Gupta P, ""Leaky"and"unstable"neural integrator can coexist-paradox observed in multiple sclerosis", J Neuroophthalmol, 40, pp.226~233 (2020)
  20. Das VE, "Experimental tests of a neural-network model for ocular oscillations caused by disease of central myelin", Exp Brain Res, 133, pp.189~197 (2000)
  21. Tzu-Pu Chang, "Pendular Oscillation and Ocular Bobbing After Pontine Hemorrhage", The Cerebellum, 20(5), pp.734~743 (2021), Springer Science and Business Media LLC[DOI]
  22. Lee SU, "Acute vestibular syndrome associated with anti-GQ1b antibody", Neurology, 93, pp.e1085~ (2019)
  23. Jung I, "Fluctuating ataxia and nystagmus in association with anti-GQ1b antibody in HIV infection", J Neurol Sci, 382, pp.123~125 (2017)
  24. 이태경, "Persistent Nystagmus in Chronic Phase of Lateral Medullary Infarction", Journal of Clinical Neurology, 16(2), pp.285~291 (2020), 대한신경과학회
  25. Johkura K, "Effects of cerebellar magnetic stimulation on chronic post-lateral medullary infarction dizziness : a proof-of-principle cohort study", J Neurol Sci, 392, pp.56~62 (2018)
  26. Minakaran N, "Charles Bonnet syndrome and periodic alternating nystagmus : moving visual hallucinations", Neurology, 92, pp.e1072~ (2019)
  27. Rim JH, "Accuracy of next-generation sequencing for molecular diagnosis in patients with infantile nystagmus syndrome", JAMA Ophthalmol, 135, pp.1376~1385 (2017)
  28. Shaikh AG, "Genome-wide association study points new direction for downbeat nystagmus research", Cerebellum, 19, pp.345~347 (2020)
  29. Strupp M, "A variation in FGF14 is associated with downbeat nystagmus in a genome-wide association study", Cerebellum, 19, pp.348~357 (2020)
  30. Young AS, "Capturing acute vertigo : a vestibular event monitor", Neurology, 92, pp.e2743~ (2019)
  31. Shaikh AG, "Consensus on virtual management of vestibular disorders : urgent versus expedited care", Cerebellum, 20, pp.4~8 (2021)
  32. Dell’Osso LF, "Congenital nystagmus waveforms and foveation strategy", Doc Ophthalmol, 39, pp.155~182 (1975)
  33. Leigh RJ, "Oscillopsia, retinal image stabilization and congenital nystagmus", Invest Ophthalmol Vis Sci, 29, pp.279~282 (1988)
  34. Dell’Osso LF, "Development and surgical removal of an epiretinal membrane in infantile nystagmus syndrome : a new type of oscillopsia", Jpn J Ophthalmol, 62, pp.249~255 (2018)
  35. Rufai SR, "Can structural grading of foveal hypoplasia predict future vision in infantile nystagmus? A longitudinal study", Ophthalmology, 127, pp.492~500 (2020)
  36. Gantz L, "Reading speed of patients with infantile nystagmus for text in different orientations", Vision Res, 155, pp.17~23 (2019)
  37. Piarroux J, "FGF14-related episodic ataxia : delineating the phenotype of episodic ataxia type 9", Ann Clin Transl Neurol, 7, pp.565~572 (2020)
  38. Delva A, "Finger extension weakness and downbeat nystagmus motor neuron disease syndrome : a novel motor neuron disorder?", Muscle Nerve, 56, pp.1164~1168 (2017)
  39. Pinto WBVR, "Finger extension weakness and downbeat nystagmus motor neurone disease(FEWDON-MND)", Pract Neurol, 19, pp.424~426 (2019)
  40. Anagnostou E, "Downbeat nystagmus and lower motor neuron disease : 14 years follow-up", J Neurol, 265, pp.714~716 (2018)
  41. Gazulla J, "Contributions to the study of spinocerebellar ataxia type 38(SCA38)", J Neurol, 267, pp.2288~2295 (2020)
  42. Lee SU, "Ictal downbeat nystagmus in Ménière disease : a cross-sectional study", Neurology, 95, pp.e2409~ (2020)
  43. Yat-Ming Woo P, "Pendular seesaw nystagmus in a patient with a giant pituitary macroadenoma : pathophysiology and the role of the accessory optic system", J Neuroophthalmol, 38, pp.65~69 (2018)
  44. Rizvi MT, "Paraneoplastic seesaw nystagmus and opsoclonus provides evidence for hyperexcitable reciprocally innervating mesencephalic network", J Neurol Sci, 390, pp.239~245 (2018)
  45. Lee SU, "Windmill nystagmus in a patient with subacute visual loss", J Neurol, 265, pp.2737~2739 (2018)
  46. Lee SU, "Pearls & oy-sters : windmill nystagmus in paraneoplastic cerebellar degeneration", Neurology, 91, pp.e1831~ (2018)
  47. Kwon E, "Pearls & oy-sters : divergence nystagmus", Neurology, 96, pp.290~293 (2021)
  48. Otero-Millan J, "Rebound nystagmus, a window into the oculomotor integrator", Prog Brain Res, 249, pp.197~209 (2019)
  49. Bodranghien F, "Consensus paper : revisiting the symptoms and signs of cerebellar syndrome", Cerebellum, 15, pp.369~391 (2016)
  50. Stefan Yu Bögli, "Cerebellar Rebound Nystagmus Explained as Gaze-Evoked Nystagmus Relative to an Eccentric Set Point: Implications for the Clinical Examination", The Cerebellum, 20(5), pp.751~759 (2021), Springer Science and Business Media LLC[DOI]
  51. Büttner U, "Diagnostic criteria for central versus peripheral positioning nystagmus and vertigo : a review", Acta Otolaryngol, 119, pp.1~5 (1999)
  52. Choung YH, "‘Bow and lean test’to determine the affected ear of horizontal canal benign paroxysmal positional vertigo", Laryngoscope, 116, pp.1776~1781 (2006)
  53. Choo OS, "Vertical nystagmus in the bow and lean test may indicate hidden posterior semicircular canal benign paroxysmal positional vertigo : hypothesis of the location of otoconia", Sci Rep, 10, pp.6514~ (2020)
  54. Fath L, "Unusual locations of benign paroxysmal positional vertigo : rare entity or regular occurrence?", Otol Neurotol, 41, pp.e735~ (2020)
  55. Kim JS, "Clinical practice. Benign paroxysmal positional vertigo", N Engl J Med, 370, pp.1138~1147 (2014)
  56. Choi SY, "Determinants for bedside lateralization of benign paroxysmal positional vertigo involving the horizontal semicircular canal", J Neurol, 267, pp.1709~1714 (2020)
  57. Scarpa A, "Lateralization of horizontal semicircular canal benign paroxysmal positional vertigo(HSC-BPPV)with the latency test : a pilot study", Acta Otolaryngol, 139, pp.854~859 (2019)
  58. Oh HJ, "Predicting a successful treatment in posterior canal benign paroxysmal positional vertigo", Neurology, 68, pp.1219~1222 (2007)
  59. Lou Y, "Orthotropic nystagmus in predicting the efficacy of treatment in posterior canal benign paroxysmal positional vertigo", Am J Otolaryngol, 41, pp.102472~ (2020)
  60. Choi JY, "Characteristics and mechanism of apogeotropic central positional nystagmus", Brain, 141, pp.762~775 (2018)
  61. Choi SY, "Persistent geotropic positional nystagmus in unilateral cerebellar lesions", Neurology, 91, pp.e1053~ (2018)
  62. Imai T, "Light cupula : the pathophysiological basis of persistent geotropic positional nystagmus", BMJ Open, 5, pp.e006607~ (2015)
  63. Kim CH, "Is the modified cupulolith repositioning maneuver effective for treatment of persistent geotropic direction-changing positional nystagmus?", Eur Arch Otorhinolaryngol, 275, pp.1731~1736 (2018)
  64. Park JS, "Effect of intratympanic steroid injection in light cupula", Acta Otolaryngol, 138, pp.769~774 (2018)
  65. Beh SC, "Horizontal direction-changing positional nystagmus and vertigo : a case of vestibular migraine masquerading as horizontal canal BPPV", Headache, 58, pp.1113~1117 (2018)
  66. Money KE, "Physical properties of fluids and structures of vestibular apparatus of the pigeon", Am J Physiol, 220, pp.140~147 (1971)
  67. Oman CM, "The physiological range of pressure difference and cupula deflections in the human semicircular canal. Theoretical considerations", Acta Otolaryngol, 74, pp.324~331 (1972)
  68. Han K, "Positional alcohol nystagmus and serum osmolality : new insights into dizziness associated with acute alcohol intoxication", Med Hypotheses, 138, pp.109606~ (2020)
  69. Bartolini E, "Acute-onset vertical nystagmus and limb tremors in chronic renal failure", J Emerg Med, 56, pp.e13~ (2019)
  70. Alkan G, "Hydroxyzine-induced vertical nystagmus", Indian Pediatr, 55, pp.1094~ (2018)
  71. Robert MP, "Intermittent upbeat nystagmus in infancy and antihistamine medications", Eur J Paediatr Neurol, 22, pp.571~572 (2018)
  72. Moore T, "Selective gating of visual signals by microstimulation of frontal cortex", Nature, 421, pp.370~373 (2003)
  73. Moore T, "Control of eye movements and spatial attention", Proc Natl Acad Sci U S A, 98, pp.1273~1276 (2001)
  74. Mastropasqua A, "Right frontal eye field has perceptual and oculomotor functions during optokinetic stimulation and nystagmus", J Neurophysiol, 123, pp.571~586 (2020)
  75. Trouillas P, "International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome", J Neurol Sci, 145, pp.205~211 (1997)
  76. Seshagiri DV, "Optokinetic nystagmus in patients with SCA : a bedside test for oculomotor dysfunction grading", Neurology, 91, pp.e1255~ (2018)
  77. Lee H, "The association of head shaking nystagmus with head-bending and lying-down nystagmus in horizontal canal benign paroxysmal positional vertigo", J Vestib Res, 30, pp.95~100 (2020)
  78. Lee SU, "Recurrent spontaneous vertigo with interictal headshaking nystagmus", Neurology, 90, pp.e2135~ (2018)
  79. Dumas G, "The skull vibration-induced nystagmus test of vestibular function-a review", Front Neurol, 8, pp.41~ (2017)
  80. Zamora EG, "Parameters of skull vibration-induced nystagmus in normal subjects", Eur Arch Otorhinolaryngol, 275, pp.1955~1961 (2018)
  81. Sinno S, "The skull vibration-induced nystagmus test : a useful vestibular screening test in children with hearing loss", Eur Ann Otorhinolaryngol Head Neck Dis, 137, pp.451~457 (2020)
  82. Wanchat Theeranaew, "Hyperventilation Increases the Randomness of Ocular Palatal Tremor Waveforms", The Cerebellum, 20(5), pp.780~787 (2021), Springer Science and Business Media LLC[DOI]
  83. Heidenreich KD, "Electrocochleography results in patients with bilateral vestibular paresis and sound-or pressure-induced horizontal nystagmus", Otol Neurotol, 39, pp.e274~ (2018)
  84. Okamoto T, "Dizziness after an earthquake tilted the house", Auris Nasus Larynx, 47, pp.1070~1073 (2020)
  85. Leigh RJ, "Effect of monocular visual loss upon stability of gaze", Invest Ophthalmol Vis Sci, 30, pp.288~292 (1989)
  86. Nguyen A, "Teaching Video NeuroImages : HeimannBielschowsky phenomenon : a harmless monocular nystagmus", Neurology, 90, pp.e731~ (2018)
  87. Nguyen A, "The Heimann-Bielschowsky phenomenon : a retrospective case series and literature review", Klin Monbl Augenheilkd, 236, pp.438~441 (2019)
  88. Tello J, "Monocular nystagmus in a patient with alternating hemiplegia of childhood", Neurology, 93, pp.361~ (2019)

관련 논문AI추천

Update of the Korean Clinical Practice Guidelines for Stroke: Blood Pressure ManagementChulho Kim, Dae-Hyun Kim, Hae-Young Lee, Hong-Kyun Park, Hye Seon Jeong, Jay Chol Choi, Jong-Moo Park, Joon-Tae Kim, Keun-Hwa Jung, Keun-Sik Hong, Min Uk Jang, Mi Sun Oh, Sang-Bae Ko, Sungha Park, Sung Hyuk Heo, Woo-Keun Seo대한신경과학회 · Journal of Clinical Neurology2025 · 제21권 제5호Blood Pressure in Acute Ischemic StrokeDavid S Liebeskind, Michael McManus대한신경과학회 · Journal of Clinical Neurology2016 · 제12권 제2호Blood Pressure Management for Stroke Prevention and in Acute Stroke홍근식대한뇌졸중학회 · 대한뇌졸중영문학회지2017 · 제19권 제2호Standard Versus Intensive Blood Pressure Control in Acute Ischemic Stroke Patients Successfully Treated With Endovascular Thrombectomy: A Systemic Review and Meta-Analysis of Randomized Controlled Trials박형종, 송태진, Gwang Hyun Leem, Minho Kim, Sung-Il Sohn, Yun Hak Kim대한뇌졸중학회 · 대한뇌졸중영문학회지2024 · 제26권 제1호Association Between Hyperacute Blood Pressure Lowering and Outcomes in Patients With Endovascular ThrombectomyByungjae Kim, Byung Moon Kim, Dong Joon Kim, Eun Lee Ko, Haram Joo, Hyo Suk Nam, Hyungwoo Lee, Jae Wook Jung, JoonNyung Heo, Young Dae Kim대한뇌졸중학회 · 대한뇌졸중영문학회지2026 · 제28권 제1호Association of Elevated Blood Pressure Levels with Outcomes in Acute Ischemic Stroke Patients Treated with Intravenous Thrombolysis: A Systematic Review and Meta-AnalysisAndrei V. Alexandrov, Angeliki Filippatou, Anne W. Alexandrov, Aristeidis H. Katsanos, Efstathios Manios, Georgios Tsivgoulis, Konark Malhotra, Konstantinos Tsioufis, Maria Pikilidou, Niaz Ahmed, Nitin Goyal, Peter D. Schellinger대한뇌졸중학회 · 대한뇌졸중영문학회지2019 · 제21권 제1호

이 간행물의 다른 논문 (26건)

Update on Nystagmus and Other Ocular Oscillations김지수, 정성해pp. 337-343Development of the Parental Questionnaire for Cerebral Visual Impairment in Children Younger than 72 Months정희정, 변정해, 문진화, 은소희, 김성구, 김건하, 은백린, 염정숙, 김승효, 노병호, 김진경, 최지은, 김준식, 김영훈pp. 354-362Acute Confusion as an Initial Presentation of SARS-CoV-2 InfectionGeberhiwot Tarekegn, Sawlani Vijay, Gautam Nandan, Madathil Shyam, Dawson Charlotte, Ochoa-Ferraro Antonio, Butt Isabelpp. 363-367Impact of an Education Program for Caregivers of Patients with Alzheimer's Disease on Treatment Discontinuation and Compliance in Korea정지향, 윤수진, 김상윤, 최성혜, 김은주, 양영순, 강경훈, 장재원, 정슬기, 박기형, 김희진, 심용수, 이찬녕, 정산pp. 368-375Discontinuation Rate of Newly Prescribed Donepezil in Alzheimer's Disease Patients in AsiaFan Dongsheng, Kandiah Nagaendran, Yang Yuan-Han, Lau Chi-ieong, Chu Leung-Wing, Wang Huali, Chou Chih-Ho, Hu Chaur-Jong, Qu Qiumin, Lin Yu-Te, Xu Yun, Li Yansheng, Zhang Zhen-Xin, Hong Zhen, Domingueze Jacqueline C., Chen Christopher, 박기형, 정산, 이찬녕, 심용수, 정지향, 정슬기, 장재원, 강경훈, 양영순, 김은주, 최성혜, 김상윤, 윤수진, 김희진pp. 376-384
원문 보기